Discontinuation report CLINIMIX E

Last updated on 2022-06-30 History
Report ID 118607
Drug Identification Number 02142376
Brand name CLINIMIX E
Common or Proper name CLINIMIX E
Company Name BAXTER CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) SODIUM ACETATE POTASSIUM PHOSPHATE DIBASIC SODIUM CHLORIDE MAGNESIUM CHLORIDE DEXTROSE L-LEUCINE L-PHENYLALANINE LYSINE METHIONINE L-ISOLEUCINE L-VALINE HISTIDINE L-THREONINE TRYPTOPHAN L-ALANINE L-ARGININE L-PROLINE SERINE GLYCINE L-TYROSINE
Strength(s) 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2000mL (JJ7771)
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-06-29
Actual discontinuation date 2022-06-29
Remaining supply date 2022-06-29
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Please refer to customer communication dated June 22, 2020 for a complete list of products being discontinued and CLINIMIX products remaining in the market. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. For ordering support of any of our products, please contact Baxter Customer Service at 1-888-719-9955.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-22 French Compare
v1 2020-06-22 English Compare

Showing 21 to 22 of 22